Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04472091

Genicular Artery Embolization (GAE) for Osteoarthritic Knee Pain

Genicular Artery Embolization for the Treatment of Moderate to Severe Osteoarthritic Knee Pain

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Andrew Picel · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The objective of this investigation is to evaluate the safety of the geniculate artery embolization (GAE) procedure with HydroPearl® Microspheres in 30 patients with knee pain caused by osteoarthritis with 24 months follow-up. The GAE procedure is an arterial embolization procedure that blocks abnormal blood vessels caused be knee arthritis in order to evaluate the effect on knee pain.

Conditions

Interventions

TypeNameDescription
DEVICEGenicular artery embolization (GAE)Participants will undergo GAE with HydroPearl® Microspheres (polyethylene glycol microspheres, Terumo Medical, Somerset NJ).

Timeline

Start date
2025-01-15
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2020-07-15
Last updated
2025-02-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04472091. Inclusion in this directory is not an endorsement.